HDAC isoform targeting offers a precision route to treating neurodegeneration
A new review argues that disease-specific HDAC isoforms, not broad-spectrum inhibition, should guide epigenetic drug development for neurodegenerative diseases.
Tag: HDAC2
POPULAR NEWS
-
Nursing decision support tool linked to lower neonatal hypoglycemia rates in hospital study
-
IVF Study Finds Progesterone-to-Oocyte Ratio Adds Little Beyond Its Parts
-
Mitochondrial Cleanup and a DNA Sensor May Team Up to Drive Stroke Inflammation
-
Smartphones, Glucose Sensors and Voice May Reveal Diabetic Minds, Review Finds